How to Qualify an Egyptian Food Manufacturer Before Ordering

The purpose is not to build the thickest supplier file It is to decide whether one named facility can repeatedly make one defined product for one destination under an agreed control plan The evidence required changes with the food, process, packaging, importer obligations and market rules

Codex places responsibility for food safety controls across the chain and uses a hazard based approach In the United States, FSVP makes the importer responsible for risk based foreign supplier verification when the rule applies Other destinations allocate obligations differently, but the operating lesson is the same: qualification must be tied to actual risk and evidence

Run the checks in sequence A failure early in the process should stop expensive sampling, artwork or travel until it is resolved

A desk review can confirm legal details, document consistency, public register status, specification quality and whether the manufacturer answers technical questions coherently It cannot prove line condition, hygiene practice, actual segregation, warehouse control or whether the named facility is really making your product

Use a site visit, independent audit or live evidence session when the risk justifies it Record the production address, line observed, product family, date and evidence reviewed A generic factory presentation is not a substitute

An attractive sample proves only that an attractive sample existed Convert it into a signed specification that fixes formulation or composition criteria, measurable attributes, tolerances, packaging, artwork, test methods, required records and the rule for changes

Then define the production evidence: retained sample, lot traceability, certificate of analysis, inspection point, sampling plan, laboratory, release authority and rejection process Price should be confirmed against that scope, not before it

One red flag is not always fraud, but unresolved inconsistency is commercial risk

A disciplined qualification process becomes more efficient when the buyer separates low cost screening from higher cost verification Start with identity, legal and site reconciliation, product capability, current registration or certification evidence, and the supplier's ability to answer a controlled technical questionnaire If those basics do not reconcile, there is little value in paying for travel, laboratory work, artwork development or a detailed commercial negotiation The sequence should deliberately stop weak candidates early rather than treating every supplier as if it deserves the same level of investigation

The next stage should test the exact product and process Ask the proposed site to confirm the product family, line, packaging format, batch or run constraints, specification control method, test methods, sample traceability and release process The purpose is not to collect impressive descriptions It is to determine whether the supplier can connect the buyer's requirement to a real production system Only after that connection is credible should the buyer invest in samples, audits, pilot orders or destination specific compliance work

The final stage is transaction readiness Confirm commercial terms, document ownership, inspection access, change control, lead time assumptions, rejection handling and the evidence that will accompany the order This staged approach protects the buyer from a common failure mode: discovering a basic mismatch only after considerable time has been invested in a supplier that was never suitable for the intended transaction

Supplier presentations often use broad statements such as export experience, modern lines, high capacity or international quality Those statements are useful only when they can be tied to the product the buyer intends to purchase Ask which line will run the product, what packaging systems are available on that line, which related products have been produced recently, what controls are used during changeover, and what records demonstrate normal production and release A plant may be generally capable while still being a poor fit for one specific product, pack or customer requirement

Capacity should also be separated into installed capability and available capability A monthly or annual headline figure does not tell the buyer whether the relevant line has space during the required production window, whether the product is seasonal, whether packaging materials create a separate constraint or whether existing commitments take priority Buyers should ask how production slots are planned and what happens when demand changes The objective is not to extract confidential production schedules, but to understand whether the quoted lead time is connected to a realistic operating plan

The same logic applies to laboratory and quality capability If a critical acceptance parameter is tested internally, confirm the method, frequency, equipment or process used and who has release authority If it is outsourced, confirm how the external result enters lot release This turns capability from a marketing claim into a controlled part of the supplier decision

A strong factory is not automatically ready for every export destination The buyer should distinguish production quality from destination readiness because border requirements, labelling, certificates, importer obligations and customer documentation can vary materially The supplier should show how destination requirements are received, reviewed, assigned and reflected in production or documentation Previous exports to a country are useful evidence, but they are not proof that the current product, classification or customer requirement is covered

Before contracting, build a responsibility matrix that shows what the manufacturer prepares, what the exporter prepares, what the importer must supply and which items depend on third parties such as laboratories, inspection bodies, chambers or carriers The matrix should also identify the latest point at which each requirement can be changed without creating rework For private label or customer specific products, artwork and label approval should be treated as controlled inputs, not as a final design task after production planning has already started

Destination readiness therefore becomes a qualification layer of its own A supplier may pass food safety and process checks yet remain commercially risky if document ownership is unclear, label review is informal or no one is responsible for checking the final consistency of invoice, packing, product and shipment data before dispatch

The first commercial order should not be treated as the end of qualification It is the first opportunity to test whether the supplier can reproduce the approved sample and specification under real production, documentation and shipment conditions Define in advance which evidence will be reviewed before release, whether inspection is required, which samples will be retained, how packaging and labels will be checked, and who can authorize shipment A first order without a defined evidence plan gives the buyer very little diagnostic value if something later goes wrong

Where commercially practical, avoid changing multiple variables at once If the first order introduces a new formulation, new package, new label, new destination and new supplier simultaneously, it becomes difficult to identify the cause of any deviation The buyer should record the approved specification version, artwork version, sample reference, purchase order assumptions and any concessions agreed for the first production Deviations should be written and time limited rather than accepted informally

After shipment, review supplier performance against the original qualification assumptions Compare actual lead time with the quoted plan, evidence delivery with the agreed matrix, product results with the specification and communication quality with the expected escalation process Qualification should become a living supplier record rather than a one time approval badge

Not every weakness has the same commercial significance A useful supplier scorecard separates approval blockers from correctable gaps and normal commercial trade offs A mismatch in legal identity, inability to demonstrate the proposed production site, refusal to sign a measurable specification or unresolved certificate inconsistency may justify stopping the process A longer lead time or higher MOQ may simply be a commercial trade off if it is clearly understood and still fits the buyer's model

Score product fit, site evidence, food safety controls, specification discipline, traceability, testing, packaging capability, destination readiness, communication, commercial transparency and corrective action behavior separately The score should reference evidence rather than intuition If a supplier receives a high rating because of a strong brand reputation but weak site level evidence, the scorecard has failed its purpose

Requalification triggers should also be defined Changes in production site, ownership, line, formulation, critical raw materials, packaging system, certification status or repeated non conformance can justify a fresh review The goal is not bureaucracy It is to make supplier approval proportional to the risk the buyer is actually accepting